For healthcare professionals. Compounded preparations are dispensed on a doctor’s prescription.

Short answer: A prescription for a compounded damiana, L-arginine, ginseng, ginkgo, multivitamin and mineral capsule names each ingredient, strength, quantity and directions for one named patient, set by the prescriber, and is prepared under Good Compounding Practice (GCP). Human evidence of benefit for this combination as a compounded capsule is not established (Journal of sex & marital therapy, 2006; PMID 16959660).

Fresh damiana leaves and sliced ginseng root arranged on a linen cloth

Why this combination reaches a prescriber

A prescriber who is asked for this combination needs to separate what the combination contains from what the trial evidence shows for a branded product with those components.

The combination trial

The main trial cited here is a double-blind, placebo-controlled study of a branded multi-ingredient product, ArginMax for women, which contains L-arginine, ginseng, ginkgo, damiana, multivitamins and minerals. It enrolled 108 women aged 22 to 73 years who reported a lack of sexual desire, and it grouped them by menopausal status (Journal of sex & marital therapy, 2006; PMID 16959660). The abstract does not report the strengths of the tested product’s components. The trial therefore does not show whether a compounded capsule with prescriber-set strengths would perform in the same way.

What the trial does not show for damiana

The trial tested the combination as a whole, so it cannot show what damiana contributes on its own (PMID 16959660). A 2026 meta-analysis of micronutrient supplementation and women’s sexual desire describes the evidence as weak and highly inconsistent, with substantial heterogeneity (I2 =87.2%) (Revista da Associacao Medica Brasileira, 2026; PMID 42961223).

How the specification is written

Because the combination is a single capsule, every component appears on the same prescription: each ingredient by name, its strength per capsule, the capsule as the form, the total quantity and the directions. Each strength is the prescriber’s decision. A change to one component changes the whole specification, so the full list should be reviewed on each order.

Why a compounded capsule rather than a shelf product

The abstract does not state the component strengths of the branded product, so this article cannot compare them with the strengths a prescriber writes for a named patient (PMID 16959660). What a compounded capsule offers is a written specification for each component, and nothing in the cited trial measures that specification.

Form prepared

The form covered here is the capsule, prepared to the prescriber’s specification. Good Compounding Practice (GCP) applies to the work carried out at the Kuala Lumpur compounding laboratory. For the general capsule-or-liquid decision, see the form-choice guide comparing capsules with oral liquids.

How to prescribe

Only a registered doctor in Malaysia writes this prescription for a named patient. Each component must be named with its strength, and the form is the capsule. Overseas prescriptions must be reviewed and re-issued by a Malaysian registered doctor first, as set out in the guide on converting an overseas prescription.

To confirm the specification before ordering, use the contact page to speak to Vitthia Rama Murti, RPh (RPh 15632). To speak to a Lynnity pharmacist about this combination, the contact route linked here is the next step.

Reviewed by Vitthia Rama Murti, RPh (RPh 15632).

Frequently asked questions

Does the trial show that damiana works on its own?

No. The placebo-controlled trial tested a multi-ingredient combination that includes damiana, and it did not test damiana alone (Journal of sex & marital therapy, 2006; PMID 16959660). Any result it reports belongs to the combination. A prescriber should not read it as evidence for damiana as a single active.

What must a prescription for this capsule state?

It must name each component: damiana, L-arginine, ginseng, ginkgo, multivitamins and minerals. For each, the strength per capsule, the total quantity and the directions are set by the prescriber, along with the form, the named patient and the prescriber’s registration details.

How strong is the evidence for this combination?

The evidence is limited. The one placebo-controlled trial tested a branded product with these components and does not report the strengths of its components, so it does not establish the effect of a compounded capsule with prescriber-set strengths (PMID 16959660). A 2026 meta-analysis of micronutrient supplementation describes the evidence for women’s sexual desire as weak and highly inconsistent (PMID 42961223).

WhatsApp us